AstraZeneca CTLA-4 Inhibitor Imjudo (Finally) Wins FDA Approval

Pharma To Carve HCC Niche On Survival Data

 
• By Alaric DeArment
  
AstraZeneca announced the approval of Imjudo, combined with Imfinzi, in HCC • Source: Shutterstock

More from New Products

More from Scrip